SHINE Medical Isotope Production Facility (Chrysalis) operating licence (accelerator-driven subcritical assemblies, Mo-99): NRC research reactor operating licence review for SHINE Medical Technologies, LLC (now SHINE Technologies, LLC) — under review. Sourced dates and schedule.
Background: NRC reactor licensing process, explained · The ADVANCE Act, explained: what changed and where the NRC stands
Current state
| Type | Research reactor operating licence |
| Outcome | Under review |
| Applicant | SHINE Medical Technologies, LLC (now SHINE Technologies, LLC) |
| Facility | SHINE Medical Isotope Production Facility, Janesville (Rock County), Wisconsin |
| Docket | 50-608 |
| Submitted | 2019-07-17 |
| Docketed (accepted for review) | 2019-10-08 |
| NRC planned schedule | — |
| NRC target date | — |
| Final safety evaluation | 2023-02-27 |
| Decision | — |
| Review time (docketed → decision) | — |
| Submitted → decision | — |
| NRC-reported review duration | — |
| NRC-reported resources vs estimate | — |
Review time is measured in average months from the date the NRC docketed the application to the decision. The NRC's own reported durations may measure to the final safety evaluation instead.
Notes
NRC target decision: 2021-10 (per SHINE release, May 11, 2020 — secondary) (month only). Premise check: no operating licence issuance was found. NRC staff finished the FSER Feb. 27, 2023 (NRC facility page shows "February 28, 2023 (NRC issued Safety Evaluation Report)") and the final SEIS Jan. 31, 2023; the NRC said it "will consider both documents in deciding whether to issue the license". The construction permit (CPMIF-001, issued Feb. 29, 2016) was extended Nov. 30, 2022 (to Dec. 31, 2025) and again Dec. 4, 2025 (to Dec. 31, 2029), so construction is incomplete and the OL decision is pending. For duration analysis use staff_review_completed (2019-10-08 to 2023-02-27, ~40.6 months) rather than a licence date. SHINE CP (2016) is outside the 2019+ window.
Timeline
- 2019-07-17 — Application received: “The U.S. Nuclear Regulatory Commission (NRC) staff accepts and dockets an application submitted by SHINE Medical Technologies, LLC (SHINE), dated July 17, 2019” (source)
- 2019-10-08 — Accepted for review (docketed): “the NRC staff performed an acceptance review of the SHINE operating license application and, by letter dated October 8, 2019 (ADAMS Accession No. ML19276D411), concluded that the application is acceptable for docketing under Docket Number 50-608.” (source)
- 2023-02-27 — Final safety evaluation issued. (source)
The timeline is append-only: corrections are added as new entries. See the NNN Data License Terms for reuse of the event history.
Sources
- https://www.federalregister.gov/documents/2019/10/15/2019-22396/shine-medical-technologies-llc
- https://www.nrc.gov/cdn/doc-collection-news/2023/23-012.pdf
- https://www.federalregister.gov/documents/2023/02/07/2023-02419/shine-medical-technologies-llc-medical-isotope-production-facility
- https://www.federalregister.gov/documents/2025/12/12/2025-22651/in-the-matter-of-shine-technologies-llc-shine-medical-isotope-production-facility-extension-of
- https://www.nrc.gov/facilities-safety/facility-finder/nonpower/shine-medical-technologies-llc
- https://www.shinefusion.com/blog/nrc-issues-review-schedule-for-shine-application